| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.2 | 7e-09 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.29 | 8e-09 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.27 | 6e-08 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.28 | 3e-07 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |